Taken together, the present findings provide integrative human evidence that coordinated upregulation of CD38 and NAMPT together with depletion of SIRT1 constitutes a molecular signature of NAD+-salvage-pathway disruption that mirrors the severity of albuminuria and renal dysfunction in type 2 diabetes. This evidence concerns the gene CD38 and type 2 diabetes mellitus.